These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32634811)

  • 1. Control of Hyperglycemia Using Differentiated and Undifferentiated Mesenchymal Stem Cells in Rats with Type 1 Diabetes.
    Aali E; Madjd Z; Tekiyehmaroof N; Sharifi AM
    Cells Tissues Organs; 2020; 209(1):13-25. PubMed ID: 32634811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat.
    Dong QY; Chen L; Gao GQ; Wang L; Song J; Chen B; Xu YX; Sun L
    Clin Invest Med; 2008 Dec; 31(6):E328-37. PubMed ID: 19032902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia.
    Xin Y; Jiang X; Wang Y; Su X; Sun M; Zhang L; Tan Y; Wintergerst KA; Li Y; Li Y
    PLoS One; 2016; 11(1):e0145838. PubMed ID: 26756576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.
    Domouky AM; Hegab AS; Al-Shahat A; Raafat N
    Int J Biochem Cell Biol; 2017 Jun; 87():77-85. PubMed ID: 28385600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cells.
    Wu XH; Liu CP; Xu KF; Mao XD; Zhu J; Jiang JJ; Cui D; Zhang M; Xu Y; Liu C
    World J Gastroenterol; 2007 Jun; 13(24):3342-9. PubMed ID: 17659673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of mesenchymal stem cells to insulin-producing cells and their impact on type 1 diabetic rats.
    Neshati Z; Matin MM; Bahrami AR; Moghimi A
    J Physiol Biochem; 2010 Jun; 66(2):181-7. PubMed ID: 20422338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of mesenchymal stem cell transplantation with its paracrine effect on control of hyperglycemia in type 1 diabetic rats.
    Aali E; Mirzamohammadi S; Ghaznavi H; Madjd Z; Larijani B; Rayegan S; Sharifi AM
    J Diabetes Metab Disord; 2014; 13(1):76. PubMed ID: 25688339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
    Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W
    Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
    Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
    Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose tissue-derived mesenchymal stromal cells efficiently differentiate into insulin-producing cells in pancreatic islet microenvironment both in vitro and in vivo.
    Karaoz E; Okcu A; Ünal ZS; Subasi C; Saglam O; Duruksu G
    Cytotherapy; 2013 May; 15(5):557-70. PubMed ID: 23388582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-producing cells from mesenchymal stromal cells: Protection against cognitive impairment in diabetic rats depends upon implant site.
    Wartchow KM; Rodrigues L; Lissner LJ; Federhen BC; Selistre NG; Moreira A; Gonçalves CA; Sesterheim P
    Life Sci; 2020 Jun; 251():117587. PubMed ID: 32224027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betacellulin overexpression in mesenchymal stem cells induces insulin secretion in vitro and ameliorates streptozotocin-induced hyperglycemia in rats.
    Paz AH; Salton GD; Ayala-Lugo A; Gomes C; Terraciano P; Scalco R; Laurino CC; Passos EP; Schneider MR; Meurer L; Cirne-Lima E
    Stem Cells Dev; 2011 Feb; 20(2):223-32. PubMed ID: 20836700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of stem cell differentiation in diabetic rats transplanted with bone marrow mesenchymal stem cells.
    Lin P; Chen L; Yang N; Sun Y; Xu YX
    Transplant Proc; 2009 Jun; 41(5):1891-3. PubMed ID: 19545751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice.
    Gabr MM; Zakaria MM; Refaie AF; Ismail AM; Abou-El-Mahasen MA; Ashamallah SA; Khater SM; El-Halawani SM; Ibrahim RY; Uin GS; Kloc M; Calne RY; Ghoneim MA
    Cell Transplant; 2013; 22(1):133-45. PubMed ID: 22710060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of different pancreatic microenvironments on improvement in hyperglycemia and insulin deficiency in diabetic rats after transplantation of allogeneic mesenchymal stromal cells.
    Katuchova J; Tothova T; Farkasova Iannaccone S; Toporcer T; Harvanova D; Hildebrand T; Kilik R; Bacenkova D; Frohlichova L; Rosocha J; Bobrov N; Radonak J
    J Surg Res; 2012 Nov; 178(1):188-95. PubMed ID: 22480834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation.
    Karnieli O; Izhar-Prato Y; Bulvik S; Efrat S
    Stem Cells; 2007 Nov; 25(11):2837-44. PubMed ID: 17615265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between the therapeutic effects of differentiated and undifferentiated Wharton's jelly mesenchymal stem cells in rats with streptozotocin-induced diabetes.
    Hsiao CY; Chen TH; Huang BS; Chen PH; Su CH; Shyu JF; Tsai PJ
    World J Stem Cells; 2020 Feb; 12(2):139-151. PubMed ID: 32184938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laminin 411 acts as a potent inducer of umbilical cord mesenchymal stem cell differentiation into insulin-producing cells.
    Qu H; Liu X; Ni Y; Jiang Y; Feng X; Xiao J; Guo Y; Kong D; Li A; Li X; Zhuang X; Wang Z; Wang Y; Chang Y; Chen S; Kong F; Zhang X; Zhao S; Sun Y; Xu D; Wang D; Zheng C
    J Transl Med; 2014 May; 12():135. PubMed ID: 24885418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro.
    Sun Y; Chen L; Hou XG; Hou WK; Dong JJ; Sun L; Tang KX; Wang B; Song J; Li H; Wang KX
    Chin Med J (Engl); 2007 May; 120(9):771-6. PubMed ID: 17531117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Under a nonadherent state, bone marrow mesenchymal stem cells can be efficiently induced into functional islet-like cell clusters to normalize hyperglycemia in mice: a control study.
    Zhang Y; Dou Z
    Stem Cell Res Ther; 2014 May; 5(3):66. PubMed ID: 24887638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.